Targeting Recipient Dendritic Cells with Sialic Acid-Modified Donor Alloantigen Prolongs Skin Transplant Survival

Area of Science:

• Immunology
• Transplantation Biology
• Cellular and Molecular Medicine

Background:

• Dendritic cells (DCs) play a dual role in immune responses, with mature DCs activating effector immunity and immature DCs inducing tolerance.
• Previous strategies for inducing transplant tolerance involved targeting immature DCs or specific DC subsets with antigens.
• Sialic acid-binding immunoglobulin-like lectins (Siglecs) on DCs are known targets for inducing tolerance, as demonstrated in experimental autoimmune encephalomyelitis.

Purpose of the Study:

• To investigate whether targeting a sialylated alloantigen (Sia-K^d) to Siglec receptors on recipient dendritic cells (DCs) could promote skin transplant survival in a mismatched mouse model.

Main Methods:

• Utilized a mismatched skin transplant model (B6K^d into B6 recipient mice).
• Administered α2,3 Sia-K^d to B6 recipient mice prior to skin transplantation.
• Analyzed the impact of Sia-K^d targeting on graft survival and regulatory T cell (Treg) populations.

Main Results:

• Targeting Sia-K^d to Siglecs on recipient DCs resulted in prolonged skin graft survival.
• This targeted approach led to an increase in CD4⁺CD62L⁺Foxp3⁺ regulatory T cells.
• The observed effects were dependent on Batf3-dependent dendritic cells.

Conclusions:

• Targeting Siglec receptors on dendritic cell subsets in vivo with specific antigens is a novel and effective strategy for improving transplant survival.
• This method holds promise for inducing immune tolerance in transplantation settings.